Naoya Nakamura

8PUBLICATIONS
37CO-AUTHORS
Immunogenetics (incl. genetic immunology)Tumour immunologyImmunology not elsewhere classifiedHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 05, 2026
AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With Double-Hit MYC and BCL2 or BCL6 and Triple Hit.

|May 15, 2024
Artificial intelligence and classification of mature lymphoid neoplasms.

Joaquim Carreras, Rifat Hamoudi, Naoya Nakamura

|Feb 20, 2024
Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease.

Asami Nishikori, Midori Filiz Nishimura, David C Fajgenbaum

|Sep 23, 2022
Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease.

Asami Nishikori, Midori Filiz Nishimura, Yoshito Nishimura

|Nov 29, 2021
PD-L1 expression is associated with the spontaneous regression of patients with methotrexate-associated lymphoproliferative disorders.

Yuka Gion, Misato Doi, Yoshito Nishimura

|Oct 27, 2021
High PTX3 expression is associated with a poor prognosis in diffuse large B-cell lymphoma.

Joaquim Carreras, Yara Yukie Kikuti, Shinichiro Hiraiwa

Pageof 2

Frequent Collaborators

3 joint publications

Midori Filiz Nishimura

3 joint publications

Asami Nishikori

3 joint publications

Yoshito Nishimura

3 joint publications

Yasuharu Sato